Flibanserin (Addyi®) vs. Flibanserin and Sex Therapy
Two Arm Open Label Pilot Study of Flibanserin (Addyi®) vs. Flibanserin and Sex Therapy
Sponsor: San Diego Sexual Medicine
Terminated
Investor Initiated Grant support stopped when drug was sold.
This PHASE4 trial investigates Hypoactive Sexual Desire Disorder and is currently terminated or withdrawn. San Diego Sexual Medicine leads this study, which shows 11 recorded versions since 2017 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
11 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE4
-
Jul 2022 — Jul 2024 [monthly]
Terminated PHASE4
-
Jan 2021 — Jul 2022 [monthly]
Terminated PHASE4
-
Nov 2019 — Jan 2021 [monthly]
Terminated PHASE4
▶ Show 6 earlier versions
-
Mar 2019 — Nov 2019 [monthly]
Terminated PHASE4
Status: Active Not Recruiting → Terminated
-
Feb 2019 — Mar 2019 [monthly]
Active Not Recruiting PHASE4
-
Sep 2018 — Feb 2019 [monthly]
Active Not Recruiting PHASE4
Status: Recruiting → Active Not Recruiting
-
Jun 2018 — Sep 2018 [monthly]
Recruiting PHASE4
-
Feb 2017 — Jun 2018 [monthly]
Recruiting PHASE4
Status: Not Yet Recruiting → Recruiting
-
Jan 2017 — Feb 2017 [monthly]
Not Yet Recruiting PHASE4
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- San Diego Sexual Medicine
For direct contact, visit the study record on ClinicalTrials.gov .